Andrew Chen, M.D. has joined University Orthopedics (UOI), headquartered in East Providence, Rhode Island, as an addition to its sports medicine team.
Andrew Chen, M.D. Joins University Orthopedics
1 min read Premium comments
#andrewchen
“We are thrilled to welcome Dr. Chen to the practice,” said Edward Akelman, M.D., president of University Orthopedics. “Just like all of the clinicians at University Orthopedics, Dr. Chen is committed to a higher level of patient care. This dedication to enhanced patient outcomes is at the heart of our practice and will make him an additional asset to our Sports Medicine team.”
As a Primary Care Sports Medicine specialist, Dr. Chen treats a wide range of sports-related injuries including finger, hand, and wrist injuries; elbow issues; shoulder issues and pathologies; hip pain and injuries; knee pain and injuries; and ankle and foot problems. He will also assist patients with chronic tendinopathies and injuries that have failed conservative treatment.
“I take pride in not only helping my patients recover from an injury, but also returning them to optimum health so they excel in the sports and activities they love,” Dr. Chen said. “I am honored and humbled to be joining such an experienced and well-regarded team like the one at University Orthopedics.”
Dr. Chen obtained his undergraduate degree at Carnegie Mellon University and an M.D. from Jefferson Medical College. A board-certified family medicine physician, Dr. Chen also recently completed a fellowship with Case Western Reserve University at University Hospitals Cleveland Medical Center. He has served as team physician for Kent State University, Lake Erie College, and Hawkin Upper School, which is a college prep school in Ohio.
Dr. Chen told OTW, “During the time between now and the opening of the Mansfield site, I’ll be working in Ortho Direct at Kettle Point in East Providence as well as in East Greenwich. I’ll also be forming my clinical team and forming relationships with physicians and schools in the area as we can be off to a running start come January 2021.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.